Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.

Download full approved condition list.

Condition name Status OMIM number Documents
Focal Segmental Glomerulosclerosis Type 1 approved 603278
Focal Segmental Glomerulosclerosis Type 2 approved 603965
Focal Segmental Glomerulosclerosis Type 5 approved 613237
Focal Segmental Glomerulosclerosis Type 6 approved 614131
Focal Segmental Glomerulosclerosis Type 8 approved 615032
Focal Segmental Glomerulosclerosis Type 9 approved 616220
Fontaine Progeroid Syndrome (FPS) approved 612289
Fragile X Syndrome (FRAX) approved 300624
Fragile XE syndrome (FRAXE) approved 309548
Fraser Syndrome approved 219000
Friedreich Ataxia 1 (FRDA) approved 229300
Frontometaphyseal Dysplasia approved 305620
Frontotemporal Dementia approved 600274
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 approved 615911
Frontotemporal dementia and/or Amyotrophic lateral sclerosis 3 approved 616437
Frontotemporal dementia and/or Amyotrophic lateral sclerosis 4 approved 616439
Galactosaemia approved 230400
Galactosialidosis (early infantile and adult / juvenile types) (GSL) approved 256540
Gangliosidosis (GM1) approved 230500
Gastrointestinal defects and immunodeficiency syndrome (GIDID) approved 243150